Efficacy and Safety of M281 in Adults With Warm Autoimmune Hemolytic Anemia

NCT04119050 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

118

Enrollment

INDUSTRY

Sponsor class

Conditions

Warm Autoimmune Hemolytic Anemia

Interventions

DRUG: M281
DRUG: Placebo

Sponsor

Janssen Research & Development, LLC